- Home
- XP vs RGC Comparison
XP vs RGC Comparison
Compare XP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XP | RGC |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | Cayman Islands | Hong Kong |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.5B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XP | RGC |
|---|---|---|
| Price | $18.63 | $27.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.17 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 92.9K |
| Earning Date | 05-19-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.00 | N/A |
| Revenue Next Year | $13.64 | N/A |
| P/E Ratio | $11.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.61 | $9.39 |
| 52 Week High | $23.13 | $950.00 |
Technical Indicators
Market Signals| Indicator | XP | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 47.88 |
| Support Level | $18.50 | $26.51 |
| Resistance Level | $20.29 | $29.26 |
| Average True Range (ATR) | 0.58 | 2.17 |
| MACD | -0.10 | -0.17 |
| Stochastic Oscillator | 20.05 | 33.54 |
Price Performance
Historical ComparisonAbout XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.